Skip to main content
. 2022 Feb 2;3:806391. doi: 10.3389/falgy.2022.806391

Table 2.

Summary of studies showing conflicting evidence about the role of IL-22 in asthma murine models.

Study Murine Model Allergen Route of sensitization Method to study IL-22 effects Phase of allergic inflammation investigated Global effect of IL-22 Effect of IL-22 on Th2 cytokines Effect of IL-22 on IL-17 Effect on eosinophilic inflammation Effect on neutrophilic inflammation Effect on AHR Effect on airway remodeling
Takahashi et al. (127) Balb/c OVA Ip Anti-IL22 Ab Se+Chal Protective
Taube et al. (128) C57BL/6 OVA Ip IL-22 KO •Se+Chal
•Chal wo Se
Protective during Se
Nakagome et al. (129) Balb/c OVA Ip •IL-22BP
•Inducible-IL-22 expression
•Se
•Se+Chal
Protective during Se ↓ only during Se ↓ (mucus) only during Se
Besnard et al. (99) C57BL/6 OVA Sc •Anti-IL22 Ab
•IL-22 KO
•Se
•Se+Chal
Pro-inflammatory during Se
•Protective during Chal
↑ only during Se ↑ only during Se ↑ only during Se ↑ (mucus) only during Se
Fang et al. (130) C57BL/6 OVA Ip •Lung-inducible
IL-22 expression
Se+Chal Protective ↓ (mucus)
Ito et al. (131) C57BL/6 HDM Intratracheal IL-22 KO Se+Chal Protective
Leyva-Castillo et al. (132) Balb/c OVA •Ec
•Ip
•Anti-IL22 Ab
•IL-22 KO
Se+Chal Pro-inflammatory with Ec Se ↑ (only after Ec Se) ↑ (requires TNFα) only after Ec Se) ↑ only after Ec Se

OVA, ovalbumin; HDM, house dust mite; Ip, intraperitoneal; Sc, subcutaneous; Ec, epicutaneous; Ab, antibody; KO, knock out gene; IL-22BP, IL-22 Binding Protein; Se, allergen sensitization; Chal, allergen challenge; wo, without; AHR, airway hyperresponsiveness.